GLP-1 RAs get explored for curing NASH, CVDs Apart from GLP-1 RA and dual agonists, drugmakers like Eli Lilly and Hanmi are also working on triple agonists
Medullary thyroid carcinoma This medicine is not recommended for use in patients with a personal or family history of medullary thyroid carcinoma due to the increased risk of worsening of the patients condition
E., & Jahoor, F
Recalls & Warnings February 13, 2013 FDA Warns Maker of Weight Loss and Whey Protein Supplements For Manufacturing Violations and Misbranding January 25, 2013, the FDA issued a warning letter to dietary supplement manufacturer SciLabs Nutraceuticals, following a facility inspection which found the company's dietary supplements and supplement ingredients, including N-Large 2, Flo-Gard AB, Nitrogen Glutamine capsules, Nutritech nutritional
Case Studies and Real-World Examples While the Purolea case is the first of its kind for drug GMP, similar issues have arisen elsewhere in life sciences: Exer Labs (Device) As noted, the February 2025 FDA warning letter to Exer Labs concerning its AI diagnostic scanner provides a complementary lesson